首页 > 最新文献

Critical Care最新文献

英文 中文
What criteria for neuropronostication: consciousness or ability? The neuro-intensivist’s dilemma 神经错乱的标准是什么:意识还是能力?神经元学家的两难选择
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-10-03 DOI: 10.1186/s13054-024-05098-5
Nicolas Engrand, Armelle Nicolas-Robin, Pierre Trouiller, Stéphane Welschbillig
<p>Rohaut et al. published the results of a remarkable 12-year evolutionary project, showing a positive association between substantial improvement in consciousness 1 month after brain injury and a favorable outcome (Glasgow Outcome Scale-Extended [GOS-E] score ≥ 4) 1 year later, with an odds ratio of 14.6 [1]. This is a major new finding on neuropronostication, a fundamental issue in neurocritical care.</p><p>The multimodal assessment (MMA) based on seven objective criteria, combined with a critical reading by a panel of experts (the “DoC team”) comprising neuro-intensivists, neurologists, neurophysiologists, neuroradiologists and neuroscientists, allowed for predicting GOS-E score 1–3 at 1 year with 100% accuracy in the group with predicted poor prognosis. Assuming that the aim of the MMA is to give a chance for neurological recovery to every patient with a capacity for recovery, these results are highly effective. This also means that at 1 month after brain injury, when the MMA and DoC team predicted a poor 1-year prognosis, they were right. So, the first important lesson for neuro-intensivists is that they can withhold or even withdraw life-sustaining therapies according to this result, without compromising a significant chance of neurological recovery, sparing the patient 1 year of invasive care and rehabilitation.</p><p>However, only 39% of the group with predicted good prognosis achieved a GOS-E score ≥ 4 (excluding withdrawal of life-sustaining therapies and unknown decisions). Similarly, only 24% of patients in the group with an uncertain prognosis achieved this good result. Therefore, the MMA’s prediction of an uncertain or favorable outcome exposed the patient to the risk of continuing treatment inappropriately, thus leading to a large number of disabilities and dependencies. In other words, there were very few early “good-prognosis patients,” and even after the MMA, 83% of the 277 patients had a GOS-E score < 4. So, although increasing the number of modalities improved accuracy, the MMA still remained not able to reliably detect long-term ability.</p><p>These results raise the question of the goal of neurocritical care.</p><p>Although it is known that all patients ultimately recover wakefulness after severe brain injury [2] and many even recover substantial consciousness [3], some will never regain the ability to interact with their environment. These latter conditions, classified as unresponsive wakefulness syndrome or vegetative state without consciousness, are widely considered failure of care. However, what about a conscious but highly dependent patient with modified Rankin Scale (mRS) score 4 or 5 or GOS-E score 4 or 3? In neurovascular studies, an mRS score of 4 (often even 3) is considered failure. For example, this score is considered an outcome to be avoided in decompressive craniectomy studies [4] (with the exception of the recent Switch study [5]) but considered a success in studies of consciousness recovery [6].</p><p>A
Rohaut 等人发表了一项历时 12 年的杰出进化项目的结果,显示脑损伤后 1 个月意识的实质性改善与 1 年后的良好预后(格拉斯哥预后量表扩展版 [GOS-E] 评分≥ 4 分)之间存在正相关,几率比为 14.6 [1]。基于七项客观标准的多模式评估(MMA),结合由神经重症监护专家、神经学家、神经生理学家、神经放射学家和神经科学家组成的专家小组("DoC 团队")的批判性解读,可以预测预后不良组 1 年后 GOS-E 评分 1-3 的准确率为 100%。假定 MMA 的目的是为每一位有康复能力的患者提供神经康复的机会,那么这些结果就是非常有效的。这也意味着,在脑损伤后 1 个月,MMA 和 DoC 团队预测 1 年预后不佳时,他们是正确的。因此,对于神经重症医生来说,第一个重要的教训就是,他们可以根据这一结果暂停甚至撤消维持生命的疗法,而不影响神经功能恢复的重要机会,使患者免于1年的侵入性护理和康复。然而,在预测预后良好的组别中,只有39%的患者达到了GOS-E评分≥4分(不包括撤消维持生命疗法和未知决定)。同样,预后不确定组中也只有 24% 的患者达到了这一良好结果。因此,MMA 对预后不确定或良好结果的预测使患者面临继续治疗不当的风险,从而导致大量残疾和依赖。换句话说,早期 "预后良好的患者 "非常少,即使在 MMA 之后,277 名患者中仍有 83% 的 GOS-E 评分为 4 分。这些结果提出了神经重症护理的目标问题。虽然众所周知,所有患者在严重脑损伤后最终都会恢复清醒[2],许多患者甚至会恢复实质性意识[3],但有些患者却永远无法恢复与环境互动的能力。后一种情况被归类为无反应清醒综合征或无意识植物状态,被广泛认为是护理失败。然而,对于意识清醒但高度依赖的患者,如果改良 Rankin 量表(mRS)评分为 4 分或 5 分,或 GOS-E 评分为 4 分或 3 分,又该如何处理呢?在神经血管研究中,mRS 评分 4 分(通常甚至是 3 分)即被视为治疗失败。例如,在颅骨减压切除术的研究中,这一评分被认为是应该避免的结果[4](最近的 Switch 研究除外[5]),但在意识恢复的研究中,这一评分被认为是成功的结果[6]。然而,即使是 mRS 评分为 5 分和患有锁闭综合征的患者,其长期满意度研究结果仍然相当乐观[8, 9]。因此,神经精神科医生的治疗目标有时与他们的神经科医生和神经外科医生的治疗目标相左,神经科医生和神经外科医生要求患者的 mRS 评分≤ 2 或 3 分,而意识专家则建议患者一旦有一丝接触的希望,就应继续治疗,同时患者的 QoL 似乎是可以接受的,或者在任何情况下都是大多数患者可以接受的。然而,MMA 过程中包含的所有临床和准临床检查(DTI-MRI 除外)都侧重于患者当前的意识状态,这难道不是有助于大量高度依赖性患者的产生吗?为了更好地针对远程 GOS-E 或 mRS 评分进行治疗,难道不应该在多学科评估小组中加入康复科医生以及老年病科医生吗?虽然从历史上看,重症监护的预后研究首先关注的是存活率,然后是预期残疾率,但现在他们可以关注质量调整生命年(包括生活质量和数量),甚至是有意识但残疾患者的满意度,尽管这更难量化[8, 10],尤其是因为失语或严重认知障碍患者的认知障碍。进一步的进展应包括更好地预测 GOS-E 或 mRS 评分,并将这一预后与患者的预嘱进行比较,同时牢记预嘱本身具有严重的局限性,尤其是在急性脑损伤的情况下[11]。
{"title":"What criteria for neuropronostication: consciousness or ability? The neuro-intensivist’s dilemma","authors":"Nicolas Engrand, Armelle Nicolas-Robin, Pierre Trouiller, Stéphane Welschbillig","doi":"10.1186/s13054-024-05098-5","DOIUrl":"https://doi.org/10.1186/s13054-024-05098-5","url":null,"abstract":"&lt;p&gt;Rohaut et al. published the results of a remarkable 12-year evolutionary project, showing a positive association between substantial improvement in consciousness 1 month after brain injury and a favorable outcome (Glasgow Outcome Scale-Extended [GOS-E] score ≥ 4) 1 year later, with an odds ratio of 14.6 [1]. This is a major new finding on neuropronostication, a fundamental issue in neurocritical care.&lt;/p&gt;&lt;p&gt;The multimodal assessment (MMA) based on seven objective criteria, combined with a critical reading by a panel of experts (the “DoC team”) comprising neuro-intensivists, neurologists, neurophysiologists, neuroradiologists and neuroscientists, allowed for predicting GOS-E score 1–3 at 1 year with 100% accuracy in the group with predicted poor prognosis. Assuming that the aim of the MMA is to give a chance for neurological recovery to every patient with a capacity for recovery, these results are highly effective. This also means that at 1 month after brain injury, when the MMA and DoC team predicted a poor 1-year prognosis, they were right. So, the first important lesson for neuro-intensivists is that they can withhold or even withdraw life-sustaining therapies according to this result, without compromising a significant chance of neurological recovery, sparing the patient 1 year of invasive care and rehabilitation.&lt;/p&gt;&lt;p&gt;However, only 39% of the group with predicted good prognosis achieved a GOS-E score ≥ 4 (excluding withdrawal of life-sustaining therapies and unknown decisions). Similarly, only 24% of patients in the group with an uncertain prognosis achieved this good result. Therefore, the MMA’s prediction of an uncertain or favorable outcome exposed the patient to the risk of continuing treatment inappropriately, thus leading to a large number of disabilities and dependencies. In other words, there were very few early “good-prognosis patients,” and even after the MMA, 83% of the 277 patients had a GOS-E score &lt; 4. So, although increasing the number of modalities improved accuracy, the MMA still remained not able to reliably detect long-term ability.&lt;/p&gt;&lt;p&gt;These results raise the question of the goal of neurocritical care.&lt;/p&gt;&lt;p&gt;Although it is known that all patients ultimately recover wakefulness after severe brain injury [2] and many even recover substantial consciousness [3], some will never regain the ability to interact with their environment. These latter conditions, classified as unresponsive wakefulness syndrome or vegetative state without consciousness, are widely considered failure of care. However, what about a conscious but highly dependent patient with modified Rankin Scale (mRS) score 4 or 5 or GOS-E score 4 or 3? In neurovascular studies, an mRS score of 4 (often even 3) is considered failure. For example, this score is considered an outcome to be avoided in decompressive craniectomy studies [4] (with the exception of the recent Switch study [5]) but considered a success in studies of consciousness recovery [6].&lt;/p&gt;&lt;p&gt;A","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"191 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142369448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus statements for the establishment of medical intensive care in low-resource settings: international study using modified Delphi methodology. 在低资源环境中建立医疗重症监护的共识声明:使用改良德尔菲方法进行的国际研究。
IF 8.8 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-10-03 DOI: 10.1186/s13054-024-05113-9
Pedja Kovacevic, Jadranka Vidovic, Boris Tomic, Jihad Mallat, Ali Ait Hssain, Muyiwa Rotimi, Owoniya Temitope Akindele, Kent Doi, Rajesh Mishra, F Joachim Meyer, Ivan Palibrk, Ranko Skrbic, Enrique Boloña, Oguz Kilickaya, Ognjen Gajic

Background: The inadequacy of intensive care medicine in low-resource settings (LRS) has become significantly more visible after the COVID-19 pandemic. Recommendations for establishing medical critical care are scarce and rarely include expert clinicians from LRS.

Methods: In December 2023, the National Association of Intensivists from Bosnia and Herzegovina organized a hybrid international conference on the topic of organizational structure of medical critical care in LRS. The conference proceedings and literature review informed expert statements across several domains. Following the conference, the statements were distributed via an online survey to conference participants and their wider professional network using a modified Delphi methodology. An agreement of ≥ 80% was required to reach a consensus on a statement.

Results: Out of the 48 invited clinicians, 43 agreed to participate. The study participants came from 20 countries and included clinician representatives from different base specialties and health authorities. After the two rounds, consensus was reached for 13 out of 16 statements across 3 domains: organizational structure, staffing, and education. The participants favored multispecialty medical intensive care units run by a medical team with formal intensive care training. Recognition and support by health care authorities was deemed critical and the panel underscored the important roles of professional organizations, clinician educators trained in high-income countries, and novel technologies such as tele-medicine and tele-education.

Conclusion: Delphi process identified a set of consensus-based statements on how to create a sustainable patient-centered medical intensive care in LRS.

背景:在 COVID-19 大流行之后,低资源环境(LRS)重症医学的不足变得更加明显。建立重症医学护理的建议很少,而且很少包括来自低资源环境的临床专家:方法:2023 年 12 月,波斯尼亚和黑塞哥维那全国重症医学专家协会组织了一次混合国际会议,主题是 LRS 重症医学护理的组织结构。会议记录和文献综述为多个领域的专家声明提供了依据。会后,采用改良的德尔菲方法,通过在线调查向与会者及其更广泛的专业网络分发了声明。结果:结果:在受邀的 48 名临床医生中,43 人同意参与。研究参与者来自 20 个国家,包括来自不同基础专科和卫生部门的临床医生代表。经过两轮讨论,在组织结构、人员配备和教育 3 个领域的 16 项声明中,有 13 项达成了共识。与会者倾向于由受过正规重症监护培训的医疗团队管理的多专科医疗重症监护病房。医疗机构的认可和支持被认为至关重要,小组强调了专业组织、在高收入国家接受过培训的临床教育工作者以及远程医疗和远程教育等新技术的重要作用:德尔菲进程确定了一套基于共识的声明,内容涉及如何在长者健康服务中创建以患者为中心的可持续医疗重症监护。
{"title":"Consensus statements for the establishment of medical intensive care in low-resource settings: international study using modified Delphi methodology.","authors":"Pedja Kovacevic, Jadranka Vidovic, Boris Tomic, Jihad Mallat, Ali Ait Hssain, Muyiwa Rotimi, Owoniya Temitope Akindele, Kent Doi, Rajesh Mishra, F Joachim Meyer, Ivan Palibrk, Ranko Skrbic, Enrique Boloña, Oguz Kilickaya, Ognjen Gajic","doi":"10.1186/s13054-024-05113-9","DOIUrl":"10.1186/s13054-024-05113-9","url":null,"abstract":"<p><strong>Background: </strong>The inadequacy of intensive care medicine in low-resource settings (LRS) has become significantly more visible after the COVID-19 pandemic. Recommendations for establishing medical critical care are scarce and rarely include expert clinicians from LRS.</p><p><strong>Methods: </strong>In December 2023, the National Association of Intensivists from Bosnia and Herzegovina organized a hybrid international conference on the topic of organizational structure of medical critical care in LRS. The conference proceedings and literature review informed expert statements across several domains. Following the conference, the statements were distributed via an online survey to conference participants and their wider professional network using a modified Delphi methodology. An agreement of ≥ 80% was required to reach a consensus on a statement.</p><p><strong>Results: </strong>Out of the 48 invited clinicians, 43 agreed to participate. The study participants came from 20 countries and included clinician representatives from different base specialties and health authorities. After the two rounds, consensus was reached for 13 out of 16 statements across 3 domains: organizational structure, staffing, and education. The participants favored multispecialty medical intensive care units run by a medical team with formal intensive care training. Recognition and support by health care authorities was deemed critical and the panel underscored the important roles of professional organizations, clinician educators trained in high-income countries, and novel technologies such as tele-medicine and tele-education.</p><p><strong>Conclusion: </strong>Delphi process identified a set of consensus-based statements on how to create a sustainable patient-centered medical intensive care in LRS.</p>","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"28 1","pages":"323"},"PeriodicalIF":8.8,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11451122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142371201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Derivation and validation of generalized sepsis-induced acute respiratory failure phenotypes among critically ill patients: a retrospective study. 重症患者中由败血症诱发的急性呼吸衰竭表型的推导和验证:一项回顾性研究。
IF 8.8 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-10-01 DOI: 10.1186/s13054-024-05061-4
Tilendra Choudhary, Pulakesh Upadhyaya, Carolyn M Davis, Philip Yang, Simon Tallowin, Felipe A Lisboa, Seth A Schobel, Craig M Coopersmith, Eric A Elster, Timothy G Buchman, Christopher J Dente, Rishikesan Kamaleswaran

Background: Septic patients who develop acute respiratory failure (ARF) requiring mechanical ventilation represent a heterogenous subgroup of critically ill patients with widely variable clinical characteristics. Identifying distinct phenotypes of these patients may reveal insights about the broader heterogeneity in the clinical course of sepsis, considering multi-organ dynamics. We aimed to derive novel phenotypes of sepsis-induced ARF using observational clinical data and investigate the generalizability of the derived phenotypes.

Methods: We performed a multi-center retrospective study of ICU patients with sepsis who required mechanical ventilation for ≥ 24 h. Data from two different high-volume academic hospital centers were used, where all phenotypes were derived in MICU of Hospital-I (N = 3225). The derived phenotypes were validated in MICU of Hospital-II (N = 848), SICU of Hospital-I (N = 1112), and SICU of Hospital-II (N = 465). Clinical data from 24 h preceding intubation was used to derive distinct phenotypes using an explainable machine learning-based clustering model interpreted by clinical experts.

Results: Four distinct ARF phenotypes were identified: A (severe multi-organ dysfunction (MOD) with a high likelihood of kidney injury and heart failure), B (severe hypoxemic respiratory failure [median P/F = 123]), C (mild hypoxia [median P/F = 240]), and D (severe MOD with a high likelihood of hepatic injury, coagulopathy, and lactic acidosis). Patients in each phenotype showed differences in clinical course and mortality rates despite similarities in demographics and admission co-morbidities. The phenotypes were reproduced in external validation utilizing the MICU of Hospital-II and SICUs from Hospital-I and -II. Kaplan-Meier analysis showed significant difference in 28-day mortality across the phenotypes (p < 0.01) and consistent across MICU and SICU of both Hospital-I and -II. The phenotypes demonstrated differences in treatment effects associated with high positive end-expiratory pressure (PEEP) strategy.

Conclusion: The phenotypes demonstrated unique patterns of organ injury and differences in clinical outcomes, which may help inform future research and clinical trial design for tailored management strategies.

背景:出现需要机械通气的急性呼吸衰竭(ARF)的败血症患者是重症患者中的一个异质性亚群,其临床特征千差万别。考虑到多器官的动态变化,识别这些患者的不同表型可能会揭示脓毒症临床过程中更广泛的异质性。我们的目的是利用临床观察数据得出脓毒症诱发 ARF 的新表型,并研究得出的表型的可推广性:我们对需要机械通气≥24小时的ICU脓毒症患者进行了一项多中心回顾性研究,数据来自两个不同的高容量学术医院中心,其中所有表型均来自医院I的MICU(N = 3225)。得出的表型在第二医院的 MICU(848 人)、第一医院的 SICU(1112 人)和第二医院的 SICU(465 人)中进行了验证。插管前 24 小时的临床数据被用来通过临床专家解释的基于机器学习的可解释聚类模型得出不同的表型:结果:确定了四种不同的 ARF 表型:A(严重多器官功能障碍(MOD),极有可能出现肾损伤和心力衰竭)、B(严重缺氧性呼吸衰竭[中位 P/F = 123])、C(轻度缺氧[中位 P/F = 240])和 D(严重 MOD,极有可能出现肝损伤、凝血病和乳酸酸中毒)。尽管人口统计学和入院并发症相似,但每种表型的患者在临床病程和死亡率上都存在差异。在外部验证中,利用第二医院的 MICU 以及第一和第二医院的 SICU 对表型进行了重现。Kaplan-Meier 分析表明,不同表型的患者 28 天死亡率存在显著差异(p 结论:表型显示了独特的器官功能模式:表型显示了器官损伤的独特模式和临床结果的差异,这可能有助于为未来的研究和临床试验设计提供信息,以制定量身定制的管理策略。
{"title":"Derivation and validation of generalized sepsis-induced acute respiratory failure phenotypes among critically ill patients: a retrospective study.","authors":"Tilendra Choudhary, Pulakesh Upadhyaya, Carolyn M Davis, Philip Yang, Simon Tallowin, Felipe A Lisboa, Seth A Schobel, Craig M Coopersmith, Eric A Elster, Timothy G Buchman, Christopher J Dente, Rishikesan Kamaleswaran","doi":"10.1186/s13054-024-05061-4","DOIUrl":"10.1186/s13054-024-05061-4","url":null,"abstract":"<p><strong>Background: </strong>Septic patients who develop acute respiratory failure (ARF) requiring mechanical ventilation represent a heterogenous subgroup of critically ill patients with widely variable clinical characteristics. Identifying distinct phenotypes of these patients may reveal insights about the broader heterogeneity in the clinical course of sepsis, considering multi-organ dynamics. We aimed to derive novel phenotypes of sepsis-induced ARF using observational clinical data and investigate the generalizability of the derived phenotypes.</p><p><strong>Methods: </strong>We performed a multi-center retrospective study of ICU patients with sepsis who required mechanical ventilation for ≥ 24 h. Data from two different high-volume academic hospital centers were used, where all phenotypes were derived in MICU of Hospital-I (N = 3225). The derived phenotypes were validated in MICU of Hospital-II (N = 848), SICU of Hospital-I (N = 1112), and SICU of Hospital-II (N = 465). Clinical data from 24 h preceding intubation was used to derive distinct phenotypes using an explainable machine learning-based clustering model interpreted by clinical experts.</p><p><strong>Results: </strong>Four distinct ARF phenotypes were identified: A (severe multi-organ dysfunction (MOD) with a high likelihood of kidney injury and heart failure), B (severe hypoxemic respiratory failure [median P/F = 123]), C (mild hypoxia [median P/F = 240]), and D (severe MOD with a high likelihood of hepatic injury, coagulopathy, and lactic acidosis). Patients in each phenotype showed differences in clinical course and mortality rates despite similarities in demographics and admission co-morbidities. The phenotypes were reproduced in external validation utilizing the MICU of Hospital-II and SICUs from Hospital-I and -II. Kaplan-Meier analysis showed significant difference in 28-day mortality across the phenotypes (p < 0.01) and consistent across MICU and SICU of both Hospital-I and -II. The phenotypes demonstrated differences in treatment effects associated with high positive end-expiratory pressure (PEEP) strategy.</p><p><strong>Conclusion: </strong>The phenotypes demonstrated unique patterns of organ injury and differences in clinical outcomes, which may help inform future research and clinical trial design for tailored management strategies.</p>","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"28 1","pages":"321"},"PeriodicalIF":8.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445942/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142361276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of mechanical versus manual cardiopulmonary resuscitation in cardiac arrest 心脏骤停时机械与人工心肺复苏术的比较
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-27 DOI: 10.1186/s13054-024-05088-7
Yang Zhao, Da Chen, Qian Wang
<p>To the editor</p><p>We read with great interest the article by El-Menyar et al., titled “Mechanical versus manual cardiopulmonary resuscitation (CPR): an umbrella review of contemporary systematic reviews and more”, recently published in <i>Critical Care</i> [1]. The findings from the umbrella review and the new systematic review in this study suggest that mechanical CPR is not superior to manual CPR in achieving return of spontaneous circulation (ROSC).</p><p>Although this article offers valuable insights, several issues warrant further discussion and clarification. In Fig. 2’s Forest plot for ROSC from El-Menyar et al.’s article, we observed some issues with the study selection. The umbrella meta-analysis included duplicated studies [2, 3] and studies with no ROSC-related data upon our detailed review [4, 5]. Additionally, the inclusion of just the abstracts from three studies [6, 7, 8] could potentially limit the robustness of the findings. Moreover, when replicating the authors’ search strategy, we identified a missing randomized controlled trial (RCT) comparing mechanical and manual CPR in in-hospital cardiac arrest (IHCA) settings [9].</p><p>We consolidated studies from the umbrella review and the new systematic review, excluding improperly included studies and adding the newly identified RCT. Using Stata Version 16.0 (StataCorp, College Station, TX), we conducted subgroup analyses for out-of-hospital cardiac arrest (OHCA) and IHCA patients across RCTs and non-RCTs. For OHCA patients, mechanical CPR did not improve ROSC rates in either study type. However, the IHCA outcomes varied by study type: RCTs showed a higher probability of ROSC with mechanical CPR, whereas non-RCTs indicated a reduced likelihood of achieving ROSC (Figs. 1 and 2)</p><figure><figcaption><b data-test="figure-caption-text">Fig. 1</b></figcaption><picture><source srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig1_HTML.png?as=webp" type="image/webp"/><img alt="figure 1" aria-describedby="Fig1" height="631" loading="lazy" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig1_HTML.png" width="685"/></picture><p>Forest plot of ROSC in mechanical CPR versus manual CPR in RCTs. ROSC, return of spontaneous circulation; CPR, cardiopulmonary resuscitation; OHCA, out-of-hospital cardiac arrest; IHCA, in-hospital cardiac arrest; RCT, randomized controlled trial; CI, confidence interval</p><span>Full size image</span><svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-chevron-right-small" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></figure><figure><figcaption><b data-test="figure-caption-text">Fig. 2</b></figcaption><picture><source srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig2_
致编辑我们饶有兴趣地阅读了 El-Menyar 等人最近发表在《重症监护》(Critical Care)[1]上的题为 "机械心肺复苏(CPR)与徒手心肺复苏(CPR):当代系统综述及其他"(Mechanical versus manual cardiopulmonary resuscitation (CPR): an umbrella review of contemporary systematic reviews and more)的文章。虽然这篇文章提供了有价值的见解,但有几个问题值得进一步讨论和澄清。在图 2 El-Menyar 等人文章中的 ROSC 森林图中,我们发现研究选择存在一些问题。总括荟萃分析包括了重复的研究[2, 3],以及经我们详细审查后没有 ROSC 相关数据的研究[4, 5]。此外,仅纳入三项研究[6、7、8]的摘要可能会限制研究结果的稳健性。此外,在复制作者的搜索策略时,我们发现了一项缺失的随机对照试验(RCT),该试验比较了院内心脏骤停(IHCA)情况下机械心肺复苏术和人工心肺复苏术[9]。我们使用 Stata 16.0 版(StataCorp,College Station,Texas)对院外心脏骤停(OHCA)和 IHCA 患者的 RCT 和非 RCT 进行了分组分析。对于院外心脏骤停患者,在两种研究类型中,机械心肺复苏都没有提高ROSC率。但是,IHCA 的结果因研究类型而异:研究表明,机械心肺复苏的 ROSC 概率较高,而非研究表明,达到 ROSC 的概率较低(图 1 和图 2)。ROSC,自主循环恢复;CPR,心肺复苏;OHCA,院外心脏骤停;IHCA,院内心脏骤停;RCT,随机对照试验;CI,置信区间全尺寸图片图 2非 RCT 中机械心肺复苏与徒手心肺复苏的 ROSC 树状图。ROSC:自发性循环恢复;CPR:心肺复苏;OHCA:院外心脏骤停;IHCA:院内心脏骤停;RCT:随机对照试验;CI:置信区间全尺寸图片。虽然我们的分析支持 El-Menyar 等人的荟萃分析中强调的机械心肺复苏并不能提高 OHCA 情况下的 ROSC 率这一结论,但 IHCA 的不同结果表明需要进一步研究。特别是,在 IHCA 情况下,RCT 与非 RCT 之间的差异意味着可能影响 CPR 结果的潜在差异。这些差异可能包括患者特征、响应时间和医院环境的不同。此外,研究设计中的局限性(如观察性研究中常见的选择偏差)也可能是影响因素之一。要确定机械心肺复苏术与徒手心肺复苏术在改善心脏骤停患者预后方面的有效性,还需要进一步开展大规模的 RCT 研究。机械心肺复苏(CPR)与徒手心肺复苏(CPR):当代系统性综述及更多综述。Crit Care.2024;28(1):259.Article PubMed PubMed Central Google Scholar Hock Ong ME、Fook-Chong S、Annathurai A、Ang SH、Tiah L、Yong KL、Koh ZX、Yap S、Sultana P. 在急诊科就诊的心脏骤停患者中使用自动负荷分配带胸外按压装置提高了神经功能完好者的存活率。Crit Care.2012;16(4):R144.Article PubMed PubMed Central Google Scholar Casner M, Andersen D, Isaacs SM.新型心肺复苏辅助装置对院外心脏骤停患者自主循环恢复率的影响》。Prehosp Emerg Care.2005; 9(1):61-7.Article PubMed Google Scholar Axelsson C, Herrera MJ, Fredriksson M, Lindqvist J, Herlitz J. 在急救医疗服务系统中对院外心脏骤停患者实施机械胸外按压。Am J Emerg Med.2013;31(8):1196-200.Article PubMed Google Scholar Jennings PA, Harriss L, Bernard S, Bray J, Walker T, Spelman T, Smith K, Cameron P. An automated CPR device compared with standard chest compressions for out-of-hospital resuscitation.BMC Emerg Med.2012; 12:8.Article PubMed PubMed Central Google Scholar Lairet JR, Lee M. A comparison of standard manual cardiopulmonary resuscitation versus the autopulse mechanical cardiopulmonary resuscitation device.Ann Emerg Med.2005; 46(3).Paradis NAKD, Ghilarducci D, Palazzolo J. 加利福尼亚自动脉冲注册指导委员会。加利福尼亚自动脉冲质量保证注册。循环。2009;120:S1457.Google Scholar Morozov SNAS, Fedorov AY.
{"title":"Comparison of mechanical versus manual cardiopulmonary resuscitation in cardiac arrest","authors":"Yang Zhao, Da Chen, Qian Wang","doi":"10.1186/s13054-024-05088-7","DOIUrl":"https://doi.org/10.1186/s13054-024-05088-7","url":null,"abstract":"&lt;p&gt;To the editor&lt;/p&gt;&lt;p&gt;We read with great interest the article by El-Menyar et al., titled “Mechanical versus manual cardiopulmonary resuscitation (CPR): an umbrella review of contemporary systematic reviews and more”, recently published in &lt;i&gt;Critical Care&lt;/i&gt; [1]. The findings from the umbrella review and the new systematic review in this study suggest that mechanical CPR is not superior to manual CPR in achieving return of spontaneous circulation (ROSC).&lt;/p&gt;&lt;p&gt;Although this article offers valuable insights, several issues warrant further discussion and clarification. In Fig. 2’s Forest plot for ROSC from El-Menyar et al.’s article, we observed some issues with the study selection. The umbrella meta-analysis included duplicated studies [2, 3] and studies with no ROSC-related data upon our detailed review [4, 5]. Additionally, the inclusion of just the abstracts from three studies [6, 7, 8] could potentially limit the robustness of the findings. Moreover, when replicating the authors’ search strategy, we identified a missing randomized controlled trial (RCT) comparing mechanical and manual CPR in in-hospital cardiac arrest (IHCA) settings [9].&lt;/p&gt;&lt;p&gt;We consolidated studies from the umbrella review and the new systematic review, excluding improperly included studies and adding the newly identified RCT. Using Stata Version 16.0 (StataCorp, College Station, TX), we conducted subgroup analyses for out-of-hospital cardiac arrest (OHCA) and IHCA patients across RCTs and non-RCTs. For OHCA patients, mechanical CPR did not improve ROSC rates in either study type. However, the IHCA outcomes varied by study type: RCTs showed a higher probability of ROSC with mechanical CPR, whereas non-RCTs indicated a reduced likelihood of achieving ROSC (Figs. 1 and 2)&lt;/p&gt;&lt;figure&gt;&lt;figcaption&gt;&lt;b data-test=\"figure-caption-text\"&gt;Fig. 1&lt;/b&gt;&lt;/figcaption&gt;&lt;picture&gt;&lt;source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig1_HTML.png?as=webp\" type=\"image/webp\"/&gt;&lt;img alt=\"figure 1\" aria-describedby=\"Fig1\" height=\"631\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig1_HTML.png\" width=\"685\"/&gt;&lt;/picture&gt;&lt;p&gt;Forest plot of ROSC in mechanical CPR versus manual CPR in RCTs. ROSC, return of spontaneous circulation; CPR, cardiopulmonary resuscitation; OHCA, out-of-hospital cardiac arrest; IHCA, in-hospital cardiac arrest; RCT, randomized controlled trial; CI, confidence interval&lt;/p&gt;&lt;span&gt;Full size image&lt;/span&gt;&lt;svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"&gt;&lt;use xlink:href=\"#icon-eds-i-chevron-right-small\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/figure&gt;&lt;figure&gt;&lt;figcaption&gt;&lt;b data-test=\"figure-caption-text\"&gt;Fig. 2&lt;/b&gt;&lt;/figcaption&gt;&lt;picture&gt;&lt;source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-024-05088-7/MediaObjects/13054_2024_5088_Fig2_","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"36 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142325485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the effectiveness of eHealth interventions in treating Post Intensive Care Syndrome (PICS) outcomes: a systematic review 探索电子保健干预措施在治疗重症监护后综合征(PICS)结果方面的有效性:系统性综述
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-27 DOI: 10.1186/s13054-024-05089-6
Daniel Jie Lai, Zhao Liu, Elaine Johnston, Lisa Dikomitis, Teresa D’Oliveira, Sukhi Shergill
It remains unclear how to optimise critical care rehabilitation to reduce the constellation of long-term physical, psychological and cognitive impairments known as Post Intensive Care Syndrome (PICS). Possible reasons for poor recovery include access to care and delayed treatment. eHealth could potentially aid in increasing access and providing consistent care remotely. Our review aimed to evaluate the effectiveness of eHealth interventions on PICS outcomes. Studies reporting eHealth interventions targeting Post Intensive Care Syndrome outcomes, published in Medline, CINAHL, PsycINFO, Embase, and Scopus from 30th January 2010 to 12th February 2024, were included in the review. Study eligibility was assessed by two reviewers with any disagreements discussed between them or resolved by a third reviewer. Study quality and risk of bias were assessed using the Mixed Method Appraisal Tool. Further to the identification of effective strategies, our review also aimed to clarify the timeline of recovery considered and the outcomes or domains targeted by the interventions. Thirteen studies were included in our review. Study duration, eHealth intervention delivery format, and outcome measures varied considerably. No studies reported a theory of behavioural change and only one study was co-produced with patients or carers. Most studies were conducted in the early post-discharge phase (i.e., < 3 months) and had feasibility as a primary outcome. The cognitive domain was the least targeted and no intervention targeted all three domains. Interventions targeting the psychological domain suggest generally positive effects. However, results were underpowered and preliminary. Though all studies were concluded to be feasible, most studies did not assess acceptability. In studies that did assess acceptability, the main facilitators of acceptability were usability and perceived usefulness, and the main barrier was sensitivity to mental health and cognitive issues. Our systematic review highlighted the promising contributions of eHealth with preliminary support for the feasibility of interventions in the early stages of post-critical care rehabilitation. Future research should focus on demonstrating effectiveness, acceptability, the cognitive domain, and multi-component interventions.
目前仍不清楚如何优化重症监护康复,以减少被称为 "重症监护后综合征"(PICS)的长期身体、心理和认知障碍。康复效果不佳的可能原因包括获得护理的机会和治疗延迟。我们的综述旨在评估电子医疗干预对 PICS 结果的有效性。综述纳入了 2010 年 1 月 30 日至 2024 年 2 月 12 日期间在 Medline、CINAHL、PsycINFO、Embase 和 Scopus 上发表的针对重症监护后综合症疗效的电子健康干预措施的研究报告。研究资格由两名审稿人进行评估,如有分歧,则由两人讨论,或由第三名审稿人解决。研究质量和偏倚风险采用混合方法评估工具进行评估。除确定有效策略外,我们的综述还旨在明确所考虑的康复时间表以及干预措施所针对的结果或领域。我们的综述共纳入了 13 项研究。研究的持续时间、电子健康干预的实施形式和结果衡量标准差异很大。没有研究报告了行为改变理论,只有一项研究是与患者或护理人员共同完成的。大多数研究都是在出院后的早期阶段(即小于 3 个月)进行的,并将可行性作为主要结果。针对认知领域的干预最少,也没有针对所有三个领域的干预。以心理领域为目标的干预措施普遍具有积极的效果。然而,这些结果都是初步性的。虽然所有研究都被认为是可行的,但大多数研究都没有评估可接受性。在评估了可接受性的研究中,可接受性的主要促进因素是可用性和感知有用性,主要障碍是对心理健康和认知问题的敏感性。我们的系统性综述强调了电子保健的巨大贡献,并初步支持在重症监护后康复的早期阶段采取干预措施的可行性。未来的研究应侧重于证明有效性、可接受性、认知领域和多成分干预措施。
{"title":"Exploring the effectiveness of eHealth interventions in treating Post Intensive Care Syndrome (PICS) outcomes: a systematic review","authors":"Daniel Jie Lai, Zhao Liu, Elaine Johnston, Lisa Dikomitis, Teresa D’Oliveira, Sukhi Shergill","doi":"10.1186/s13054-024-05089-6","DOIUrl":"https://doi.org/10.1186/s13054-024-05089-6","url":null,"abstract":"It remains unclear how to optimise critical care rehabilitation to reduce the constellation of long-term physical, psychological and cognitive impairments known as Post Intensive Care Syndrome (PICS). Possible reasons for poor recovery include access to care and delayed treatment. eHealth could potentially aid in increasing access and providing consistent care remotely. Our review aimed to evaluate the effectiveness of eHealth interventions on PICS outcomes. Studies reporting eHealth interventions targeting Post Intensive Care Syndrome outcomes, published in Medline, CINAHL, PsycINFO, Embase, and Scopus from 30th January 2010 to 12th February 2024, were included in the review. Study eligibility was assessed by two reviewers with any disagreements discussed between them or resolved by a third reviewer. Study quality and risk of bias were assessed using the Mixed Method Appraisal Tool. Further to the identification of effective strategies, our review also aimed to clarify the timeline of recovery considered and the outcomes or domains targeted by the interventions. Thirteen studies were included in our review. Study duration, eHealth intervention delivery format, and outcome measures varied considerably. No studies reported a theory of behavioural change and only one study was co-produced with patients or carers. Most studies were conducted in the early post-discharge phase (i.e., < 3 months) and had feasibility as a primary outcome. The cognitive domain was the least targeted and no intervention targeted all three domains. Interventions targeting the psychological domain suggest generally positive effects. However, results were underpowered and preliminary. Though all studies were concluded to be feasible, most studies did not assess acceptability. In studies that did assess acceptability, the main facilitators of acceptability were usability and perceived usefulness, and the main barrier was sensitivity to mental health and cognitive issues. Our systematic review highlighted the promising contributions of eHealth with preliminary support for the feasibility of interventions in the early stages of post-critical care rehabilitation. Future research should focus on demonstrating effectiveness, acceptability, the cognitive domain, and multi-component interventions.","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"31 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142325488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between SARS-CoV-2 infection and ICU-acquired candidemia in critically ill medical patients: a multicenter prospective cohort study 重症内科病人 SARS-CoV-2 感染与重症监护室获得性念珠菌血症之间的关系:一项多中心前瞻性队列研究
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-27 DOI: 10.1186/s13054-024-05104-w
Florian Reizine, Nicolas Massart, Alexandre Mansour, Yannick Fedun, Anaïs Machut, Charles-Hervé Vacheron, Anne Savey, Arnaud Friggeri, Alain Lepape
While SARS-CoV2 infection has been shown to be a significant risk-factor for several secondary bacterial, viral and Aspergillus infections, its impact on intensive care unit (ICU)-acquired candidemia (ICAC) remains poorly explored. Using the REA-REZO network (French surveillance network of ICU-acquired infections), we included all adult patients hospitalized for a medical reason of admission in participating ICUs for at least 48 h from January 2020 to January 2023. To account for confounders, a non-parsimonious propensity score matching was performed. Rates of ICAC according to SARS-CoV2 status were compared in matched patients. Factors associated with ICAC in COVID-19 patients were also assessed using a Fine-Gray model. A total of 55,268 patients hospitalized at least 48 h for a medical reason in 101 ICUs were included along the study period. Of those, 13,472 were tested positive for a SARS-CoV2 infection while 284 patients developed an ICAC. ICAC rate was higher in COVID-19 patients in both the overall population and the matched patients’ cohort (0.8% (107/13,472) versus 0.4% (173/41,796); p < 0.001 and 0.8% (93/12,241) versus 0.5% (57/12,241); p = 0.004, respectively). ICAC incidence rate was also higher in those patients (incidence rate 0.51 per 1000 patients-days in COVID-19 patients versus 0.32 per 1000 patients-days; incidence rate ratio: 1.58 [95% CI:1.08–2.35]; p = 0.018). Finally, patients with ICAC had a higher ICU mortality rate (49.6% versus 20.2%; p < 0.001). In this large multicenter cohort of ICU patients, although remaining low, the rate of ICAC was higher among COVID-19 patients.
SARS-CoV2感染已被证明是多种继发性细菌、病毒和曲霉菌感染的重要风险因素,但其对重症监护病房(ICU)获得性念珠菌血症(ICAC)的影响仍未得到充分探讨。我们利用 REA-REZO 网络(法国重症监护病房获得性感染监测网络),纳入了 2020 年 1 月至 2023 年 1 月期间因医疗原因在参与网络的重症监护病房住院至少 48 小时的所有成人患者。为了考虑混杂因素,我们进行了非拟合倾向评分匹配。根据 SARS-CoV2 状态比较了匹配患者的 ICAC 发生率。还使用 Fine-Gray 模型评估了与 COVID-19 患者 ICAC 相关的因素。在研究期间,共有 55268 名患者因医疗原因在 101 个重症监护病房住院至少 48 小时。其中,13,472 名患者的 SARS-CoV2 感染检测呈阳性,284 名患者出现了 ICAC。在总体人群和匹配患者队列中,COVID-19 患者的 ICAC 发生率较高(分别为 0.8%(107/13,472)对 0.4%(173/41,796);p < 0.001 和 0.8%(93/12,241)对 0.5%(57/12,241);p = 0.004)。这些患者的 ICAC 发病率也更高(COVID-19 患者的发病率为每 1000 个患者日 0.51 例,而 COVID-19 患者的发病率为每 1000 个患者日 0.32 例;发病率比:1.58 [95% CI:1.08-2.35]; p = 0.018)。最后,ICAC 患者的 ICU 死亡率更高(49.6% 对 20.2%;P < 0.001)。在这一大型多中心 ICU 患者队列中,COVID-19 患者的 ICAC 发生率虽然仍然较低,但却较高。
{"title":"Relationship between SARS-CoV-2 infection and ICU-acquired candidemia in critically ill medical patients: a multicenter prospective cohort study","authors":"Florian Reizine, Nicolas Massart, Alexandre Mansour, Yannick Fedun, Anaïs Machut, Charles-Hervé Vacheron, Anne Savey, Arnaud Friggeri, Alain Lepape","doi":"10.1186/s13054-024-05104-w","DOIUrl":"https://doi.org/10.1186/s13054-024-05104-w","url":null,"abstract":"While SARS-CoV2 infection has been shown to be a significant risk-factor for several secondary bacterial, viral and Aspergillus infections, its impact on intensive care unit (ICU)-acquired candidemia (ICAC) remains poorly explored. Using the REA-REZO network (French surveillance network of ICU-acquired infections), we included all adult patients hospitalized for a medical reason of admission in participating ICUs for at least 48 h from January 2020 to January 2023. To account for confounders, a non-parsimonious propensity score matching was performed. Rates of ICAC according to SARS-CoV2 status were compared in matched patients. Factors associated with ICAC in COVID-19 patients were also assessed using a Fine-Gray model. A total of 55,268 patients hospitalized at least 48 h for a medical reason in 101 ICUs were included along the study period. Of those, 13,472 were tested positive for a SARS-CoV2 infection while 284 patients developed an ICAC. ICAC rate was higher in COVID-19 patients in both the overall population and the matched patients’ cohort (0.8% (107/13,472) versus 0.4% (173/41,796); p < 0.001 and 0.8% (93/12,241) versus 0.5% (57/12,241); p = 0.004, respectively). ICAC incidence rate was also higher in those patients (incidence rate 0.51 per 1000 patients-days in COVID-19 patients versus 0.32 per 1000 patients-days; incidence rate ratio: 1.58 [95% CI:1.08–2.35]; p = 0.018). Finally, patients with ICAC had a higher ICU mortality rate (49.6% versus 20.2%; p < 0.001). In this large multicenter cohort of ICU patients, although remaining low, the rate of ICAC was higher among COVID-19 patients.","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"4 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142325484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The INTOXICATE study: methodology and preliminary results of a prospective observational study INTOXICATE 研究:前瞻性观察研究的方法和初步结果
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-27 DOI: 10.1186/s13054-024-05096-7
Samanta M. Zwaag, Irma S. van den Hengel-Koot, Stuart Baker, Patrick Druwé, Muhammed Elhadi, Ana Ferrer Dufol, Sune Forsberg, Burcin Halacli, Christian Jung, Gabija Laubner Sakalauskienė, Elin Lindqvist, Rui Moreno, Christian Rabe, Nanna Reiter, Richard Rezar, Radu Țincu, Arzu Topeli, David M. Wood, Dylan W. de Lange, Claudine C. Hunault
There is currently no practice-based, multicenter database of poisoned patients admitted to intensive care units (ICUs). The INTOXICATE study, endorsed by the ESICM and EAPCCT, aimed to determine the rate of eventful admissions among acutely intoxicated adult ICU patients. Ethical approval was obtained for this multicenter, prospective observational study, and data-sharing agreements were signed with each participating center. An electronic case report form was used to collect data on patient demographics, exposure, clinical characteristics, investigations, treatment, and in-hospital mortality data. The primary outcome, ‘eventful admission’, was a composite outcome defined as the rate of patients who received any of the following treatments in the first 24 h after the ICU admission: oxygen supplementation with a FiO2 > 40%, mechanical ventilation, vasopressors, renal replacement therapy (RRT), cardiopulmonary resuscitation, antidotes, active cooling, fluid resuscitation (> 1.5 L of intravenous fluid of any kind), sedation, or who died in the hospital. Seventy-eight ICUs, mainly from Europe, but also from Australia and the Eastern Mediterranean, participated. A total of 2,273 patients were enrolled between November 2020 and June 2023. The median age of the patients was 41 years, 72% were exposed to intoxicating drugs. The observed rate of patients with an eventful ICU admission was 68% (n = 1546/2273 patients). The hospital mortality was 4.5% (n = 103/2273). The vast majority of patients survive, and approximately one third of patients do not receive any ICU-specific interventions after admission in an intensive care unit for acute intoxication. High-quality detailed clinical data have been collected from a large cohort of acutely intoxicated ICU patients, providing information on the pattern of severe acute poisoning requiring intensive care admission and the outcomes of these patients. Trial registration: OSF registration ID: osf.io/7e5uy.
目前,重症监护病房(ICU)尚未建立以实践为基础的中毒患者多中心数据库。INTOXICATE 研究得到了 ESICM 和 EAPCCT 的支持,旨在确定急性中毒成人重症监护病房患者的事件性入院率。这项多中心、前瞻性观察研究已获得伦理批准,并与各参与中心签署了数据共享协议。研究采用电子病例报告表收集患者的人口统计学数据、接触情况、临床特征、检查、治疗和院内死亡率数据。主要研究结果 "入院事件 "是一项综合研究结果,其定义为患者在入住重症监护病房后的 24 小时内接受以下任何一种治疗的比例:FiO2 > 40% 的氧气补充、机械通气、血管加压、肾脏替代疗法(RRT)、心肺复苏、解毒剂、主动降温、液体复苏(> 1.5 L 的各种静脉注射液)、镇静或在医院内死亡。共有 78 家重症监护室参与了这项研究,其中主要来自欧洲,也有来自澳大利亚和地中海东部的重症监护室。在 2020 年 11 月至 2023 年 6 月期间,共有 2273 名患者参与了这项研究。患者的年龄中位数为 41 岁,72% 的患者接触过麻醉药物。观察到的重症监护室入院患者事件发生率为 68%(n = 1546/2273)。住院死亡率为 4.5%(n = 103/2273)。绝大多数患者都能存活,约三分之一的患者在因急性中毒入住重症监护室后没有接受任何重症监护室特定的干预措施。该研究从一大批急性中毒重症监护室患者中收集到了高质量的详细临床数据,为需要入住重症监护室的严重急性中毒模式以及这些患者的预后提供了信息。试验注册:OSF 注册编号:osf.io/7e5uy。
{"title":"The INTOXICATE study: methodology and preliminary results of a prospective observational study","authors":"Samanta M. Zwaag, Irma S. van den Hengel-Koot, Stuart Baker, Patrick Druwé, Muhammed Elhadi, Ana Ferrer Dufol, Sune Forsberg, Burcin Halacli, Christian Jung, Gabija Laubner Sakalauskienė, Elin Lindqvist, Rui Moreno, Christian Rabe, Nanna Reiter, Richard Rezar, Radu Țincu, Arzu Topeli, David M. Wood, Dylan W. de Lange, Claudine C. Hunault","doi":"10.1186/s13054-024-05096-7","DOIUrl":"https://doi.org/10.1186/s13054-024-05096-7","url":null,"abstract":"There is currently no practice-based, multicenter database of poisoned patients admitted to intensive care units (ICUs). The INTOXICATE study, endorsed by the ESICM and EAPCCT, aimed to determine the rate of eventful admissions among acutely intoxicated adult ICU patients. Ethical approval was obtained for this multicenter, prospective observational study, and data-sharing agreements were signed with each participating center. An electronic case report form was used to collect data on patient demographics, exposure, clinical characteristics, investigations, treatment, and in-hospital mortality data. The primary outcome, ‘eventful admission’, was a composite outcome defined as the rate of patients who received any of the following treatments in the first 24 h after the ICU admission: oxygen supplementation with a FiO2 > 40%, mechanical ventilation, vasopressors, renal replacement therapy (RRT), cardiopulmonary resuscitation, antidotes, active cooling, fluid resuscitation (> 1.5 L of intravenous fluid of any kind), sedation, or who died in the hospital. Seventy-eight ICUs, mainly from Europe, but also from Australia and the Eastern Mediterranean, participated. A total of 2,273 patients were enrolled between November 2020 and June 2023. The median age of the patients was 41 years, 72% were exposed to intoxicating drugs. The observed rate of patients with an eventful ICU admission was 68% (n = 1546/2273 patients). The hospital mortality was 4.5% (n = 103/2273). The vast majority of patients survive, and approximately one third of patients do not receive any ICU-specific interventions after admission in an intensive care unit for acute intoxication. High-quality detailed clinical data have been collected from a large cohort of acutely intoxicated ICU patients, providing information on the pattern of severe acute poisoning requiring intensive care admission and the outcomes of these patients. Trial registration: OSF registration ID: osf.io/7e5uy.","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"25 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142325630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic role of early blood gas variables in critically ill patients with Pneumocystis jirovecii pneumonia: a retrospective analysis 肺孢子虫肺炎重症患者早期血气变量的预后作用:回顾性分析
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-27 DOI: 10.1186/s13054-024-05087-8
Anouk Voutaz, Jean Bonnemain, Zied Ltaief, Oriol Manuel, Lucas Liaudet
<p><i>Pneumocystis jirovecii</i> pneumonia (PJP) is a severe fungal opportunistic infection occurring in immunocompromised patients, commonly associated with Human Immunodeficiency Virus (HIV) in the past and nowadays increasingly diagnosed in non-HIV patients with immune suppression. Severe PJP requiring admission to the intensive care unit is associated with mortality rates > 50%, and several factors have been associated with reduced survival including age, a non-HIV status, invasive mechanical ventilation and the admission SOFA score [1, 2]. Whether additional prognostic factors might help identify high-risk patients at an early stage of ICU stay remains undefined. To address this issue, we retrospectively analyzed (study protocol approved by our ethical committee, CER-VD Nr 2020-00201) the clinical and early (admission—day 0- and day 1) arterial blood gas (ABG) variables, including values of methemoglobin (MetHb) and carboxyhemoglobin (HbCO), in a cohort of PJP patients admitted to our multidisciplinary ICU between 2006 and 2019. The primary outcome was mortality at day 60. Data were compared between survivors and non survivors using the Wilcoxon’s rank sum test and the Pearson’s chi-squared test, and univariate logistic regression analyses were done to evaluate associations between variables and 60-day mortality. We also performed a multivariable analysis incorporating invasive mechanical ventilation at day 1 as a possible confounder, with blood gas data at day 1 (PaCO<sub>2</sub>, HbCO and MetHb) as explanatory co-variables. The impact of blood gas variables on 60-day survival was further assessed using Kaplan–Meier plots and log-rank test analysis.</p><p>A total of 37 patients with confirmed <i>Pneumocystis jirovecii</i> infection (except in one patient in whom no sample could be obtained, but with typical clinical/radiological presentation and a positive beta-glucan test) were included. Underlying diagnoses were malignancy (n = 21), chronic immune-mediated inflammatory disease (n = 8), HIV (n = 5), solid organ (n = 4) or bone marrow transplantation (n = 5), with more than 1 condition present in 6 patients. Most patients had been treated prior to admission with one or more immune suppressive therapies. The 60-day mortality was 51% (19/37 patients). Non-survivors were significantly older but did not differ from survivors with respect to gender and underlying diagnoses. All patients received non-invasive and/or invasive respiratory support, and non-survivors required significantly more often invasive mechanical ventilation (79 vs. 39%, <i>p</i> < 0.05). ABG analyses showed that non-survivors had higher PaCO<sub>2</sub> (day 1), lower pHa and higher MetHb as well as a trend for higher HbCO (day 0 and day 1). In contrast, P/F O<sub>2</sub> was comparable in survivors and non-survivors at the two time-points. In univariate analyses, day 0 HbCO and MetHb, and day 1 PaCO<sub>2</sub>, pHa and MetHb were significantly associated with 60-day m
吉罗韦氏肺孢子菌肺炎(PJP)是一种严重的真菌机会性感染,多发于免疫力低下的患者,过去通常与人类免疫缺陷病毒(HIV)有关,如今越来越多的非 HIV 患者因免疫抑制而被诊断为 PJP。需要入住重症监护室的重症 PJP 死亡率高达 50%,有几个因素与存活率降低有关,包括年龄、非 HIV 感染状况、有创机械通气和入院 SOFA 评分[1, 2]。其他预后因素是否有助于在入住 ICU 的早期阶段识别高危患者,目前仍未确定。为了解决这个问题,我们回顾性分析了 2006 年至 2019 年期间入住我们多学科 ICU 的一组 PJP 患者的临床和早期(入院第 0 天和第 1 天)动脉血气(ABG)变量(研究方案已获伦理委员会批准,CER-VD Nr 2020-00201),包括高铁血红蛋白(MetHb)和碳氧血红蛋白(HbCO)的值。主要结果是第 60 天的死亡率。我们使用 Wilcoxon 秩和检验和皮尔逊卡方检验比较了存活者和非存活者之间的数据,并进行了单变量逻辑回归分析,以评估变量与 60 天死亡率之间的关联。我们还进行了多变量分析,将第 1 天的有创机械通气作为可能的混杂因素,并将第 1 天的血气数据(PaCO2、HbCO 和 MetHb)作为解释性共变因素。共纳入 37 名确诊为肺孢子虫感染的患者(除一名患者无法获得样本,但具有典型的临床/放射学表现和β-葡聚糖检测呈阳性外)。基础诊断包括恶性肿瘤(21 例)、慢性免疫介导的炎症性疾病(8 例)、艾滋病(5 例)、实体器官移植(4 例)或骨髓移植(5 例),其中 6 例患者患有一种以上的疾病。大多数患者在入院前曾接受过一种或多种免疫抑制疗法。60天死亡率为51%(19/37名患者)。非幸存者的年龄明显偏大,但在性别和基础诊断方面与幸存者没有差异。所有患者都接受了非侵入性和/或侵入性呼吸支持,非存活者需要侵入性机械通气的比例明显更高(79 比 39%,P &lt;0.05)。ABG 分析显示,非存活者的 PaCO2(第 1 天)较高,pHa 较低,MetHb 较高,HbCO(第 0 天和第 1 天)也呈上升趋势。相比之下,幸存者和非幸存者在两个时间点的 P/F O2 值相当。在单变量分析中,第 0 天的 HbCO 和 MetHb 以及第 1 天的 PaCO2、pHa 和 MetHb 与 60 天死亡率显著相关(图 1A)。在多变量分析中,第 1 天的 PaCO2 和 MetHb 仍与 60 天死亡率显著相关(图 1B)。Kaplan-Meier 分析显示,第 0 天 MetHb 较高和 pHa 较低的患者(图中未显示),以及第 1 天 HbCO、PaCO2 和 MetHb 较高和 pHa 较低的患者(图 1C)生存期明显较短。A 存活者和非存活者在第 0 天和第 1 天的 P/FO2、PaCO2、pHa、HbCO 和 MetHb(中位数,四分位数间差)及其与 60 天死亡率的单变量关系。B 与 60 天死亡率相关因素的多变量分析。C Kaplan-Meier 图显示 60 天观察期内存活者的比例与第 1 天的 PaCO2(单位:mmHg)、pHa、MetHb 和 HbCO 的函数关系,并根据其在整个队列中的中位值进行二分。对于连续变量,计算了每单位变化的几率比(OR)和 95% 置信区间(CI)(P/FO2:10 mmHg;PaCO2:1 mmHg;pHa:0.01 pH 单位;HbCO:0.1%;MetHb:0.1%)。注:第 0 天,1 名患者(存活者)的 P/FO2 缺失,3 名患者(2 名存活者,1 名非存活者)未测量 HbCO 和 MetHB。第 1 天:3 名患者(1 名非存活者,2 名存活者)未获得 ABG,其中 HbCO 和 MetHb 是通过中心静脉血气分析获得的。IMV 有创机械通气全尺寸图片我们的研究发现,在入住 ICU 的头 24 小时内获得的几个 ABG 变量可为 PJP 患者提供重要的早期预后信息。非存活患者较高的 PaCO2 和较低的 pHa 可能反映了呼吸疲劳的发展或死腔通气的增加,这与其他形式的急性呼吸衰竭中较高的死腔分数的负面影响是一致的[3]。非存活者的 MetHb 水平也较高,其第 0 天和第 1 天的值与 60 天死亡率显著相关。
{"title":"Prognostic role of early blood gas variables in critically ill patients with Pneumocystis jirovecii pneumonia: a retrospective analysis","authors":"Anouk Voutaz, Jean Bonnemain, Zied Ltaief, Oriol Manuel, Lucas Liaudet","doi":"10.1186/s13054-024-05087-8","DOIUrl":"https://doi.org/10.1186/s13054-024-05087-8","url":null,"abstract":"&lt;p&gt;&lt;i&gt;Pneumocystis jirovecii&lt;/i&gt; pneumonia (PJP) is a severe fungal opportunistic infection occurring in immunocompromised patients, commonly associated with Human Immunodeficiency Virus (HIV) in the past and nowadays increasingly diagnosed in non-HIV patients with immune suppression. Severe PJP requiring admission to the intensive care unit is associated with mortality rates &gt; 50%, and several factors have been associated with reduced survival including age, a non-HIV status, invasive mechanical ventilation and the admission SOFA score [1, 2]. Whether additional prognostic factors might help identify high-risk patients at an early stage of ICU stay remains undefined. To address this issue, we retrospectively analyzed (study protocol approved by our ethical committee, CER-VD Nr 2020-00201) the clinical and early (admission—day 0- and day 1) arterial blood gas (ABG) variables, including values of methemoglobin (MetHb) and carboxyhemoglobin (HbCO), in a cohort of PJP patients admitted to our multidisciplinary ICU between 2006 and 2019. The primary outcome was mortality at day 60. Data were compared between survivors and non survivors using the Wilcoxon’s rank sum test and the Pearson’s chi-squared test, and univariate logistic regression analyses were done to evaluate associations between variables and 60-day mortality. We also performed a multivariable analysis incorporating invasive mechanical ventilation at day 1 as a possible confounder, with blood gas data at day 1 (PaCO&lt;sub&gt;2&lt;/sub&gt;, HbCO and MetHb) as explanatory co-variables. The impact of blood gas variables on 60-day survival was further assessed using Kaplan–Meier plots and log-rank test analysis.&lt;/p&gt;&lt;p&gt;A total of 37 patients with confirmed &lt;i&gt;Pneumocystis jirovecii&lt;/i&gt; infection (except in one patient in whom no sample could be obtained, but with typical clinical/radiological presentation and a positive beta-glucan test) were included. Underlying diagnoses were malignancy (n = 21), chronic immune-mediated inflammatory disease (n = 8), HIV (n = 5), solid organ (n = 4) or bone marrow transplantation (n = 5), with more than 1 condition present in 6 patients. Most patients had been treated prior to admission with one or more immune suppressive therapies. The 60-day mortality was 51% (19/37 patients). Non-survivors were significantly older but did not differ from survivors with respect to gender and underlying diagnoses. All patients received non-invasive and/or invasive respiratory support, and non-survivors required significantly more often invasive mechanical ventilation (79 vs. 39%, &lt;i&gt;p&lt;/i&gt; &lt; 0.05). ABG analyses showed that non-survivors had higher PaCO&lt;sub&gt;2&lt;/sub&gt; (day 1), lower pHa and higher MetHb as well as a trend for higher HbCO (day 0 and day 1). In contrast, P/F O&lt;sub&gt;2&lt;/sub&gt; was comparable in survivors and non-survivors at the two time-points. In univariate analyses, day 0 HbCO and MetHb, and day 1 PaCO&lt;sub&gt;2&lt;/sub&gt;, pHa and MetHb were significantly associated with 60-day m","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"41 1","pages":""},"PeriodicalIF":15.1,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142325486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphopenia in sepsis: a narrative review 败血症中的淋巴细胞减少症:叙述性综述
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-20 DOI: 10.1186/s13054-024-05099-4
Zhibin Wang, Wenzhao Zhang, Linlin Chen, Xin Lu, Ye Tu
This narrative review provides an overview of the evolving significance of lymphopenia in sepsis, emphasizing its critical function in this complex and heterogeneous disease. We describe the causal relationship of lymphopenia with clinical outcomes, sustained immunosuppression, and its correlation with sepsis prediction markers and therapeutic targets. The primary mechanisms of septic lymphopenia are highlighted. In addition, the paper summarizes various attempts to treat lymphopenia and highlights the practical significance of promoting lymphocyte proliferation as the next research direction.
这篇叙述性综述概述了淋巴细胞减少症在脓毒症中不断演变的意义,强调了淋巴细胞减少症在这种复杂而多变的疾病中的关键作用。我们描述了淋巴细胞减少症与临床结果、持续免疫抑制的因果关系,以及它与脓毒症预测指标和治疗目标的相关性。文章还强调了脓毒症淋巴细胞减少症的主要机制。此外,本文还总结了治疗淋巴细胞减少症的各种尝试,并强调了促进淋巴细胞增殖作为下一个研究方向的现实意义。
{"title":"Lymphopenia in sepsis: a narrative review","authors":"Zhibin Wang, Wenzhao Zhang, Linlin Chen, Xin Lu, Ye Tu","doi":"10.1186/s13054-024-05099-4","DOIUrl":"https://doi.org/10.1186/s13054-024-05099-4","url":null,"abstract":"This narrative review provides an overview of the evolving significance of lymphopenia in sepsis, emphasizing its critical function in this complex and heterogeneous disease. We describe the causal relationship of lymphopenia with clinical outcomes, sustained immunosuppression, and its correlation with sepsis prediction markers and therapeutic targets. The primary mechanisms of septic lymphopenia are highlighted. In addition, the paper summarizes various attempts to treat lymphopenia and highlights the practical significance of promoting lymphocyte proliferation as the next research direction. ","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"190 1","pages":"315"},"PeriodicalIF":15.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142276053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infusion of sodium DL-3-ß-hydroxybutyrate decreases cerebral injury biomarkers after resuscitation in experimental cardiac arrest 输注 DL-3-ß-hydroxybutyrate 钠可减少实验性心脏骤停患者复苏后的脑损伤生物标志物
IF 15.1 1区 医学 Q1 CRITICAL CARE MEDICINE Pub Date : 2024-09-20 DOI: 10.1186/s13054-024-05106-8
Filippo Annoni, Fuhong Su, Lorenzo Peluso, Ilaria Lisi, Enrico Caruso, Francesca Pischiutta, Elisa Gouvea Bogossian, Bruno Garcia, Hassane Njimi, Jean-Louis Vincent, Nicolas Gaspard, Lorenzo Ferlini, Jacques Creteur, Elisa R. Zanier, Fabio Silvio Taccone
Cerebral complications after cardiac arrest (CA) remain a major problem worldwide. The aim was to test the effects of sodium-ß-hydroxybutyrate (SBHB) infusion on brain injury in a clinically relevant swine model of CA. CA was electrically induced in 20 adult swine. After 10 min, cardiopulmonary resuscitation was performed for 5 min. After return of spontaneous circulation (ROSC), the animals were randomly assigned to receive an infusion of balanced crystalloid (controls, n = 11) or SBHB (theoretical osmolarity 1189 mOsm/l, n = 8) for 12 h. Multimodal neurological and cardiovascular monitoring were implemented in all animals. Nineteen of the 20 animals achieved ROSC. Blood sodium concentrations, osmolarity and circulating KBs were higher in the treated animals than in the controls. SBHB infusion was associated with significantly lower plasma biomarkers of brain injury at 6 (glial fibrillary acid protein, GFAP and neuron specific enolase, NSE) and 12 h (neurofilament light chain, NFL, GFAP and NSE) compared to controls. The amplitude of the stereoelectroencephalograph (sEEG) increased in treated animals after ROSC compared to controls. Cerebral glucose uptake was lower in treated animals. In this experimental model, SBHB infusion after resuscitated CA was associated with reduced circulating markers of cerebral injury and increased sEEG amplitude.
心脏骤停(CA)后的脑部并发症仍然是世界范围内的一个主要问题。本研究旨在测试输注ß-羟基丁酸钠(SBHB)对临床相关的 CA 猪模型脑损伤的影响。对 20 头成年猪进行电诱导 CA。10 分钟后,进行心肺复苏 5 分钟。自发性循环恢复(ROSC)后,动物被随机分配接受平衡晶体液(对照组,n = 11)或 SBHB(理论渗透压 1189 mOsm/l,n = 8)输注 12 小时。20 只动物中有 19 只实现了 ROSC。接受治疗的动物的血钠浓度、渗透压和循环中的 KBs 均高于对照组。与对照组相比,输注 SBHB 在 6 小时(胶质纤维酸蛋白、GFAP 和神经元特异性烯醇化酶、NSE)和 12 小时(神经丝轻链、NFL、GFAP 和 NSE)脑损伤血浆生物标志物明显降低。与对照组相比,ROSC 后接受治疗的动物立体脑电图(sEEG)振幅增大。治疗动物的脑葡萄糖摄取量较低。在该实验模型中,CA复苏后输注SBHB与脑损伤循环标志物减少和sEEG振幅增加有关。
{"title":"Infusion of sodium DL-3-ß-hydroxybutyrate decreases cerebral injury biomarkers after resuscitation in experimental cardiac arrest","authors":"Filippo Annoni, Fuhong Su, Lorenzo Peluso, Ilaria Lisi, Enrico Caruso, Francesca Pischiutta, Elisa Gouvea Bogossian, Bruno Garcia, Hassane Njimi, Jean-Louis Vincent, Nicolas Gaspard, Lorenzo Ferlini, Jacques Creteur, Elisa R. Zanier, Fabio Silvio Taccone","doi":"10.1186/s13054-024-05106-8","DOIUrl":"https://doi.org/10.1186/s13054-024-05106-8","url":null,"abstract":"Cerebral complications after cardiac arrest (CA) remain a major problem worldwide. The aim was to test the effects of sodium-ß-hydroxybutyrate (SBHB) infusion on brain injury in a clinically relevant swine model of CA. CA was electrically induced in 20 adult swine. After 10 min, cardiopulmonary resuscitation was performed for 5 min. After return of spontaneous circulation (ROSC), the animals were randomly assigned to receive an infusion of balanced crystalloid (controls, n = 11) or SBHB (theoretical osmolarity 1189 mOsm/l, n = 8) for 12 h. Multimodal neurological and cardiovascular monitoring were implemented in all animals. Nineteen of the 20 animals achieved ROSC. Blood sodium concentrations, osmolarity and circulating KBs were higher in the treated animals than in the controls. SBHB infusion was associated with significantly lower plasma biomarkers of brain injury at 6 (glial fibrillary acid protein, GFAP and neuron specific enolase, NSE) and 12 h (neurofilament light chain, NFL, GFAP and NSE) compared to controls. The amplitude of the stereoelectroencephalograph (sEEG) increased in treated animals after ROSC compared to controls. Cerebral glucose uptake was lower in treated animals. In this experimental model, SBHB infusion after resuscitated CA was associated with reduced circulating markers of cerebral injury and increased sEEG amplitude.","PeriodicalId":10811,"journal":{"name":"Critical Care","volume":"12 1","pages":"314"},"PeriodicalIF":15.1,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142276044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Critical Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1